90 related articles for article (PubMed ID: 8547042)
41. Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid.
Hegarty JH; Halvorsen L; Hazenberg BP; Nowak A; Smith CL; Thomson AB; Vantrappen G; McKenna CJ; Mills JG
Can J Gastroenterol; 1997; 11(1):83-8. PubMed ID: 9113805
[TBL] [Abstract][Full Text] [Related]
42. Bedtime treatment of duodenal ulcer.
Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
[No Abstract] [Full Text] [Related]
43. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[TBL] [Abstract][Full Text] [Related]
45. Healing of gastric ulcers after one, two, and three months of ranitidine.
Ashton MG; Holdsworth CD; Ryan FP; Moore M
Br Med J (Clin Res Ed); 1982 Feb; 284(6314):467-8. PubMed ID: 6120738
[TBL] [Abstract][Full Text] [Related]
46. Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients.
Cossu ML; Caccia S; Coppola M; Fais E; Ruggiu M; Fracasso C; Nacca A; Noya G
Obes Surg; 1999 Feb; 9(1):36-9. PubMed ID: 10065579
[TBL] [Abstract][Full Text] [Related]
47. Pilot Study to Evaluate the Efficacy and Safety of Oral Tacrolimus in Adult Patients With Refractory Severe Plaque Psoriasis.
Mittal A; Dogra S; Narang T; Sharma A
J Cutan Med Surg; 2016 May; 20(3):228-32. PubMed ID: 26553734
[TBL] [Abstract][Full Text] [Related]
48. Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
Leonardi C; Maari C; Philipp S; Goldblum O; Zhang L; Burkhardt N; Ball S; Mallbris L; Gonzalez P; Fernández-Peñas P; Puig L
J Am Acad Dermatol; 2018 Nov; 79(5):824-830.e2. PubMed ID: 29803904
[TBL] [Abstract][Full Text] [Related]
49. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
50. The efficacy and optimum time of administration of ranitidine in the prevention of the acid aspiration syndrome.
Escolano F; Sierra P; Ortiz JC; Cabrera JC; Castaño J
Anaesthesia; 1996 Feb; 51(2):182-4. PubMed ID: 8779379
[TBL] [Abstract][Full Text] [Related]
51. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of clinical use of etanercept for the treatment of moderate-to-severe psoriasis in Spain: results of a multicentric prospective study at 12 months follow-up.
Puig L; Camacho Martínez FM; Gimeno Carpio E; López-Ávila A; García-Calvo C
Dermatology; 2012; 225(3):220-30. PubMed ID: 23235195
[TBL] [Abstract][Full Text] [Related]
53. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
54. [Regression of primary gastric lymphoma after treatment with ranitidine].
Tassinari D; Sartori S; Cangiotti C; Gianni L; Rinaldi P; Ravaioli A; Iorio D
Recenti Prog Med; 1997 Apr; 88(4):179-80. PubMed ID: 9206815
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
56. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of weekly azathioprine pulse in the treatment of chronic plaque psoriasis: an open-label study.
Verma P; Verma KK; Khanna N; Gupta S; Bhari N
Clin Exp Dermatol; 2016 Oct; 41(7):717-22. PubMed ID: 27663145
[TBL] [Abstract][Full Text] [Related]
58. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
59. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
[TBL] [Abstract][Full Text] [Related]
60. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
